Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Nov, 17 2025
Mar, 25 2025
Feb, 1 2026
Dec, 3 2025
Dec, 5 2025